Article Details
Retrieved on: 2021-05-24 16:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... a clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral infections, ... 50% of these patients had inadequate response, loss of response, ...
Article found on: www.digitaljournal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here